Kawasumi Laboratories Blood Drawing Kit (BDK) System— 510(k) K172957

Substantially Equivalent

Kawasumi Laboratories, Inc.

FDA 510(k) clearance K172957 for Kawasumi Laboratories Blood Drawing Kit (BDK) System, Substantially Equivalent on 2018-09-28. Applicant: Kawasumi Laboratories, Inc..

Clearance details

Applicant: Kawasumi Laboratories, Inc.
Product code: Code KSB
Advisory panel: Hematology
Date received: 2017-09-26
Decision date: 2018-09-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tokyo, JP

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.